O que já sabemos sobre a Síndrome Pós-COVID-19: Uma revisão narrativa
DOI:
https://doi.org/10.33448/rsd-v11i12.34143Palavras-chave:
COVID-19; SARS-CoV-2; Tosse; Fatiga; Doença crônica.Resumo
Como um número crescente de pacientes que se recuperam da doença aguda COVID-19, tem sido observado que muitos enfrentam sintomas de longa duração, chamados de Síndrome Pós-COVID-19. Este artigo cobre os sinais e sintomas mais comuns desta síndrome, seus aspectos gerais e exames complementares importantes relacionados com a doença. O manuscrito é uma revisão narrativa, reunindo novas evidências publicadas sobre o tema. Os sintomas mais comuns da Síndrome Pós-COVID-19 são fadiga crônica, falta de ar, depressão ou ansiedade, dor, tosse e alopecia, e muitos deles ainda estão presentes 6 meses após a alta hospitalar da doença aguda, dependendo da gravidade da doença. É importante para os pacientes manter um acompanhamento médico para ter acesso à gravidade dos sintomas e escolher se é necessária uma investigação mais aprofundada. Há alguns tratamentos disponíveis para alguns minimizar a carga duradoura da síndrome, e o médico deve ter acesso à necessidade de tratamento com o paciente. Como uma nova doença, há muitas evidências novas sendo produzidas rapidamente, mas nenhum protocolo atualizado já foi publicado. Mesmo com as campanhas de vacinação, o fardo da pandemia ainda está fora de vista, pois ainda mata milhares diariamente, e aqueles que se recuperaram da doença aguda COVID-19 podem apresentar sintomas crônicos. Portanto, recomendamos aos profissionais de saúde que se atualizem continuamente, pois novas informações são acrescentadas para tomar melhores decisões clínicas.
Referências
Ahmed H, Patel K, Greenwood D, Halpin S, Lewthwaite P, Salawu A, et al. (2020). Long-term clinical outcomes in survivors of severe acute respiratory syndrome and Middle East respiratory syndrome coronavirus outbreaks after hospitalisation or ICU admission: A systematic review and meta-analysis. J Rehabil Med [Internet]. https://doi.org/10.2340/16501977-2694.
Alimohamadi Y, Sepandi M, Taghdir M & Hosamirudsari H. (2020). Determine the most common clinical symptoms in COVID-19 patients: a systematic review and meta-analysis. J Prev Med Hyg [Internet]. 61(3):E304–12. https://doi.org/doi: 10.15167/2421-4248/jpmh2020.61.3.1530.
Arnold D. T, Hamilton F. W, Milne A, Morley A. J, Viner J, Attwood M, et al. (2021). Patient outcomes after hospitalisation with COVID-19 and implications for follow-up: results from a prospective UK cohort. Thorax [Internet].76(4):399–401. https://doi.org/10.1136/thoraxjnl-2020-216086.
Barker-Davies R. M, O’Sullivan O, Senaratne KPP, Baker P, Cranley M, Dharm-Datta S, et al. (2020). The Stanford Hall consensus statement for post-COVID-19 rehabilitation. Br J Sports Med [Internet]. 54(16):949–59. https://doi.org/10.1136/bjsports-2020-102596.
Bowles K. H, McDonald M, Barrón Y, Kennedy E, O’Connor M, Mikkelsen M. (2021). Surviving COVID-19 After Hospital Discharge: Symptom, Functional, and Adverse Outcomes of Home Health Recipients. Ann Intern Med [Internet]. 174(3):316–25. https://doi.org/10.7326/M20-5206.
Carfì A, Bernabei R & Landi F. (2020). Persistent Symptoms in Patients After Acute COVID-19. JAMA [Internet]. 324(6):603. https://doi.org/10.1001/jama.2020.12603.
Carod Artal FJ. (2021). Síndrome post-COVID-19: epidemiología, criterios diagnósticos y mecanismos patogénicos implicados. Rev Neurol [Internet]. 72(11):384. https://doi.org/10.33588/rn.7211.2021230.CDC. (2021). Post-COVID Conditions.
Damm M, Pikart LK, Reimann H, Burkert S, Göktas Ö, Haxel B, et al. (2014). Olfactory training is helpful in postinfectious olfactory loss: A randomized, controlled, multicenter study. Laryngoscope [Internet]. 124(4):826–31. https://doi.org/10.1002/lary.24340 Available from: https://onlinelibrary.wiley.com/doi/10.1002/lary.24340
Dicpinigaitis, P. V., & Canning, B. J. (2020). Is There (Will There Be) a Post-COVID-19 Chronic Cough?. Lung, 198(6), 863–865. https://doi.org/10.1007/s00408-020-00406-6
Durmus E & Guneysu F. (2020). Evaluation of re-hospitalized COVID-19 patients in a hospital. Rev Assoc Med Bras [Internet]. 66(12):1690–5. https://doi.org/10.1590/1806-9282.66.12.1690.
Dyspnea. Mechanisms, assessment, and management: a consensus statement. (1999). American Thoracic Society. Am J Respir Crit Care Med. 59(1):321-40. 10.1164/ajrccm.159.1.ats898.
Goërtz Y. M. J, Van Herck M, Delbressine J. M, Vaes A. W, Meys R, Machado F. V. C. et al. (2020). Persistent symptoms 3 months after a SARS-CoV-2 infection: the post-COVID-19 syndrome? ERJ Open Res [Internet]. 6(4):00542–2020. https://doi.org/10.1183/23120541.00542-2020.
Greenhalgh T, Knight M, A’Court C, Buxton M, Husain L. (2020). Management of post-acute covid-19 in primary care. BMJ [Internet]. m3026. https://doi.org/10.1136/bmj.m3026.
Guan, W. J., Ni, Z. Y., Hu, Y., Liang, W. H., Ou, C. Q., He, J. X., Liu, L., Shan, H., Lei, C. L., Hui, D., Du, B., Li, L. J., Zeng, G., Yuen, K. Y., Chen, R. C., Tang, C. L., Wang, T., Chen, P. Y., Xiang, J., Li, S. Y. China Medical Treatment Expert Group for Covid-19 (2020). Clinical Characteristics of Coronavirus Disease 2019 in China. The New England journal of medicine, 382(18), 1708–1720. https://doi.org/10.1056/NEJMoa2002032.
Hadid T, Kafri Z & Al-Katib A. (2021). Coagulation and anticoagulation in COVID-19. Blood Rev [Internet]. 47:100761. https://doi.org/10.1016/j.blre.2020.100761.
Halpin SJ, McIvor C, Whyatt G, Adams A, Harvey O, McLean L, et al. (2021). Postdischarge symptoms and rehabilitation needs in survivors of COVID‐19 infection: A cross‐sectional evaluation. J Med Virol [Internet]. 93(2):1013–22. https://doi.org/10.1002/jmv.26368.
Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. (2021). 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet [Internet]. 397(10270):220–32. https://doi.org/10.1016/S0140-6736(20)32656-8. https://linkinghub.elsevier.com/retrieve/pii/S0140673620326568
Liu K, Zhang W, Yang Y, Zhang J, Li Y & Chen Y. (2020). Respiratory rehabilitation in elderly patients with COVID-19: A randomized controlled study. Complement Ther Clin Pract [Internet]. 39:101166. https://doi.org/10.1016/j.ctcp.2020.101166.
Meini S, Suardi LR, Busoni M, Roberts AT & Fortini A. (2020). Olfactory and gustatory dysfunctions in 100 patients hospitalized for COVID-19: sex differences and recovery time in real-life. Eur Arch Oto-Rhino-Laryngology [Internet]. 277(12):3519–23. https://doi.org/10.1007/s00405-020-06102-8.
Mikkelsen AME & Abramoff B. (2021). COVID-19 : Evaluation and management of adults following acute viral illness. Up to Date [Internet]. 2019:1–34. https://www.uptodate.com/contents/covid-19-evaluation-and-management-of-adults-following-acute-viral-illness?search=covid 19 respiratory& source= search_result&selectedTitle=1~150&usage_type=default&display_rank=1
National Institute for Health and Care Excellence. (2020). Venous thromboembolic diseases: diagnosis, management and thrombophilia testing (clinical guideline CG144) [Internet].
Nalbandian A, Sehgal K, Gupta A, Madhavan M V., McGroder C, Stevens JS, et al. (2021). Post-acute COVID-19 syndrome. Nat Med [Internet]. 22;27(4):601–15. https://doi.org/10.1038/s41591-021-01283-z.
O’Connor FG & Franzos A. (2021). COVID-19: Return to play or strenuous activity following infection [Internet]. Up to Date.
O’Driscoll BR, Howard LS, Earis J, Mak V. (2017). BTS guideline for oxygen use in adults in healthcare and emergency settings. Thorax [Internet]. 72(Suppl 1):ii1–90. https://doi.org/10.1136/thoraxjnl-2016-209729.
Oliviero A., de Castro F., Coperchini F., Chiovato L., Rotondi M. (2020). COVID-19 pulmonary and olfactory dysfunctions: is the chemokine CXCL10 the common denominator? Neuroscientist. 1–8. doi: 10.1177/1073858420939033.
Ortelli, P., Ferrazzoli, D., Sebastianelli, L., Engl, M., Romanello, R., Nardone, R., Bonini, I., Koch, G., Saltuari, L., Quartarone, A., Oliviero, A., Kofler, M., & Versace, V. (2021). Neuropsychological and neurophysiological correlates of fatigue in post-acute patients with neurological manifestations of COVID-19: Insights into a challenging symptom. Journal of the neurological sciences, 420, 117271. https://doi.org/10.1016/j.jns.2020.117271.
Perico, L., Benigni, A., Casiraghi, F., Ng, L., Renia, L., & Remuzzi, G. (2021). Immunity, endothelial injury and complement-induced coagulopathy in COVID-19. Nature reviews. Nephrology, 17(1), 46–64. https://doi.org/10.1038/s41581-020-00357-4
Piraccini BM & Alessandrini A. (2014). Androgenetic alopecia. G Ital Dermatol Venereol [Internet]. 149(1):15–24.
Rawal G, Yadav S & Kumar R. (2017). Post-intensive care syndrome: An overview. J Transl Intern Med [Internet]. 5(2):90–2. https://doi.org/10.1515/jtim-2016-0016.
Rodríguez-Larrad A, Mañas A, Labayen I, González-Gross M, Espin A, Aznar S, et al. (2021). Impact of COVID-19 Confinement on Physical Activity and Sedentary Behaviour in Spanish University Students: Role of Gender. Int J Environ Res Public Health [Internet].;18(2):369. https://doi.org/10.3390/ijerph18020369.
Scangas GA & Bleier BS. (2017). Anosmia: Differential Diagnosis, Evaluation, and Management. Am J Rhinol Allergy [Internet]. 31(1):e3–7. https://doi.org/10.2500/ajra.2017.31.4403.
Sonnweber T, Sahanic S, Pizzini A, Luger A, Schwabl C, Sonnweber B, et al. (2021). Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J [Internet]. 57(4):2003481. https://doi.org/10.1183/13993003.03481-2020.
Spiezia L, Boscolo A, Poletto F, Cerruti L, Tiberio I, Campello E, et al. (2020). COVID-19-Related Severe Hypercoagulability in Patients Admitted to Intensive Care Unit for Acute Respiratory Failure. Thromb Haemost [Internet]. 120(06):998–1000. https://doi.org/10.1055/s-0040-1710018.
Tang N, Li D, Wang X & Sun Z. (2020). Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost [Internet].18(4):844–7. https://doi.org/10.1111/jth.14768.
Teixeira T. A, Bernardes F. S, Oliveira Y. C, Hsieh M. K, Esteves S. C, Duarte Neto A. N, et al. (2021). SARS-CoV-2 and Multi-Organ damage – What men’s health specialists should know about the COVID-19 pathophysiology. Int braz j urol [Internet].47(3):637–46. https://doi.org/10.1590/S1677-5538.IBJU.2020.0872.
Thachil, J., Tang, N., Gando, S., Falanga, A., Cattaneo, M., Levi, M., Clark, C., & Iba, T. (2020). ISTH interim guidance on recognition and management of coagulopathy in COVID-19. Journal of thrombosis and haemostasis : JTH, 18(5), 1023–1026. https://doi.org/10.1111/jth.14810
Udelson J. E, Rowin E. J & Maron B. J. (2021). Return to Play for Athletes After COVID-19 Infection. JAMA Cardiol [Internet]. https://doi.org/10.1001/jamacardio.2021.2079.
Xiong Q, Xu M, Li J, Liu Y, Zhang J, Xu Y, et al. (2021). Clinical sequelae of COVID-19 survivors in Wuhan, China: a single-centre longitudinal study. Clin Microbiol Infect. 27(1):89–95. 10.1016/j.cmi.2020.09.023.
Wade D., Hardy R. & Howell DMM. (2013). Identifying clinical and acute psychological risk factors for PTSD after critical care: a systematic review. EmbaseMinerva Anestesiol. 2013;79(8):944–63.
Wambier C. G, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, et al. (2020). Androgenetic alopecia present in the majority of patients hospitalized with COVID-19: The “Gabrin sign.” J Am Acad Dermatol [Internet]. 83(2):680–2.https://doi.org/10.1016/j.jaad.2020.05.079.
Wasserman D, Guzman-Sanchez DA, Scott K & McMichael A. (2007). Alopecia areata. Int J Dermatol [Internet]. 46(2):121–31. https://doi.org/10.1111/j.1365-4632.2007.03193.x Available from: https://onlinelibrary.wiley.com/doi/10.1111/j.1365-4632.2007.03193.x
Wootton DG, Dickinson L, Pertinez H, Court J, Eneje O, Keogan L, et al. (2017). A longitudinal modelling study estimates acute symptoms of community acquired pneumonia recover to baseline by 10 days. Eur Respir J [Internet]. 49(6):1602170. https://doi.org/10.1183/13993003.02170-2016.
Zhou P, Yang X-L, Wang X-G, Hu B, Zhang L, Zhang W, et al. (2020). A pneumonia outbreak associated with a new coronavirus of probable bat origin. Nature [Internet]. 579(7798):270–3. https://doi.org/10.1038/s41586-020-2012-7.
Downloads
Publicado
Como Citar
Edição
Seção
Licença
Copyright (c) 2022 Mariana Dias de Resende; Gabriel Dias de Resende; Lucas Nunes Riquieri; Ana Flávia Arantes dos Santos; Alexandre Cesar Alves de Castro; Mariana da Costa Rocha
Este trabalho está licenciado sob uma licença Creative Commons Attribution 4.0 International License.
Autores que publicam nesta revista concordam com os seguintes termos:
1) Autores mantém os direitos autorais e concedem à revista o direito de primeira publicação, com o trabalho simultaneamente licenciado sob a Licença Creative Commons Attribution que permite o compartilhamento do trabalho com reconhecimento da autoria e publicação inicial nesta revista.
2) Autores têm autorização para assumir contratos adicionais separadamente, para distribuição não-exclusiva da versão do trabalho publicada nesta revista (ex.: publicar em repositório institucional ou como capítulo de livro), com reconhecimento de autoria e publicação inicial nesta revista.
3) Autores têm permissão e são estimulados a publicar e distribuir seu trabalho online (ex.: em repositórios institucionais ou na sua página pessoal) a qualquer ponto antes ou durante o processo editorial, já que isso pode gerar alterações produtivas, bem como aumentar o impacto e a citação do trabalho publicado.
